EORTC protocol 62063

A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to Imatinib mesylate.
Trial StatusOpen
DatesDate of activation: 20/05/2009
Data management at EORTCFull
Phase3
Randomized trialNo
Type-
Targeted Sample sizeEORTC Groups: 280 - All Groups: 350
Number of steps1
DrugImatinib mesylate (STI-571)
Study StaffAlessandro Gronchi (Study Coordinator) - Istituto Nazionale Per Lo Studio E La Cura Dei Tumori, Milano
Martine Van Glabbeke (Statistician) - EORTC, Brussels
Catherine Hermans (Data Manager) - EORTC, Brussels
Sandrine Marreaud (Coordinating Physician) - EORTC, Brussels
Anne Kirkpatrick (Project Manager) - EORTC, Brussels, anne.kirkpatrick( at )eortc.be, +32 2 7741691
Type of cancerGastric
Soft Tissue and Bone Sarcoma
Participating GroupsEORTC Soft Tissue and Bone Sarcoma Group(Coordinating Group)
Australasian Gastro-Intestinal Trials Group
Federation Nationale des Centres de Lutte contre le Cancer
French Sarcoma Group
Grupo Espanol de Investigacion en sarcomas
Italian Sarcoma Group
Currently authorized centers Peter Maccallum Cancer Institute (East Melbourne, Australia) - Inst. 1054
Institut Gustave Roussy (Villejuif, France) - Inst. 225
Centre Leon Berard (Lyon, France) - Inst. 227
Institut Bergonie (Bordeaux, France) - Inst. 228
Centre Rene Gauducheau (Nantes - St. Herblain, France) - Inst. 235
Centre Alexis Vautrin (Vandoeuvre-Les-Nancy, France) - Inst. 250
Institut Curie (Paris, France) - Inst. 259
Assistance Publique - Hôpitaux de Marseille - C.H.U. De La Timone (Marseille, France) - Inst. 287
Istituto Europeo Di Oncologia (Milano, Italy) - Inst. 3869
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori (Napoli, Italy) - Inst. 3870
Istituto Clinico Humanitas (Rozzano, Milano, Italy) - Inst. 3901
Istituto Oncologico Veneto IRCCS - Ospedale Busonera (Padova, Italy) - Inst. 3908
Ospedale Gradenigo (Torino, Italy) - Inst. 3920
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (Meldola, Italy) - Inst. 9074
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori (Milano, Italy) - Inst. 704
Centro Di Riferimento Oncologico (Aviano, Italy) - Inst. 772
Ospedale Civile Belluno (Belluno, Italy) - Inst. 840
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, The Netherlands) - Inst. 301
Erasmus University Medical Center (Rotterdam, The Netherlands) - Inst. 302
Radboud University Nijmegen Medical Centre (Nijmegen, The Netherlands) - Inst. 304
Leiden University Medical Centre (Leiden, The Netherlands) - Inst. 310
University Medical Center Groningen (Groningen, The Netherlands) - Inst. 335
Christie Hospital (Manchester, United Kingdom) - Inst. 610
University College Hospital (London, United Kingdom) - Inst. 622
Protocol summaryLink provided by NCI PDQ
Protocol documents in PDF (requires password)62063.pdf
Back to Protocol section